You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Nonergot Dopamine Agonist Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: Nonergot Dopamine Agonist

Glossary
ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Alembic Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090429-001 Mar 24, 2010 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Dr Reddys Labs Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 201576-003 Jun 6, 2012 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Glenmark Pharms Ltd ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090135-001 Feb 25, 2010 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Mlv ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 079165-006 Feb 7, 2012 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Norvium Bioscience ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 078881-005 May 5, 2008 DISCN No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Orbion Pharms ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 079229-004 Nov 28, 2012 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration

Subscribe to access the full database, or Try for Free

Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group